GCICLS inks expanded leasing deal at Hamburg property
announced a significant leasing agreement at its Fangdieckstrasse 75 property in Hamburg on Wednesday, securing over 8,900 square metres of office and laboratory space.
The London-listed firm said the Hamburg Institut für Pathologie und Hämatopathologie (HPH), a specialist in diagnosing haematological diseases, had extended its current lease for 5,628 square metres until 2035, and added 3,311 sqm of additional space, bringing its total occupancy to 8,939 square metres.
It said the institute would move into the new space this month, following the departure of the current tenant, ensuring the property remained fully leased.
Fangdieckstrasse 75, acquired by CLS in 2007, had been transformed by the company into a science and healthcare hub.
The building has a total of 13,092 square metres of office, industrial, and laboratory space and is located near the Science City Hamburg Bahrenfeld area - a centre for science and technology start-ups, with excellent transport links.
"We are thrilled that HPH has not only extended their existing lease for over 10 years but has also chosen to lease additional space in Fangdieckstrasse 75," said chief executive officer Fredrik Widlund.
"Hamburg-Bahrenfeld is an up-and-coming commercial area and CLS has successfully repositioned the property as an attractive location for science and technology organisations, and demand from occupiers in this sector remains high."
At 0946 BST, shares in CLS Holdings were up 0.76% at 92.5p.
Reporting by Josh White for Sharecast.com.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.